Gupta Piyush, Dabas Aashima, Seth Anju, Bhatia Vijay Lakshmi, Khadgawat Rajesh, Kumar Praveen, Balasubramanian S, Khadilkar Vaman, Mallikarjuna H B, Godbole Tushar, Krishnamurthy Sriram, Goyal Jagdish Prasad, Bhakhri Bhanu Kiran, Ahmad Ayesha, Angadi Kumar, Basavaraj G V, Parekh Bakul J, Kurpad Anura, Marwaha R K, Shah Dheeraj, Munns Craig, Sachdev H P S
Department of Pediatrics, University College of Medical Sciences, New Delhi. Correspondence to: Dr Piyush Gupta, Professor and Head, Department of Pediatrics, University College of Medical Sciences, and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi 110095, India.
Department of Pediatrics, Maulana Azad Medical College, New Delhi.
Indian Pediatr. 2022 Feb 15;59(2):142-158. Epub 2021 Dec 29.
The emerging literature on prevalence of vitamin D deficiency in India, prevention and treatment strategies of rickets, and extra-skeletal benefits of vitamin D suggest the need for revising the existing guidelines for prevention and treatment of vitamin D deficiency in India.
To review the emerging literature on vitamin D prevalence and need for universal vitamin D supplementation. To suggest optimum vitamin D therapy for treatment of asymptomatic and symptomatic vitamin D deficiency, and rickets. To evaluate the extra-skeletal health benefits of vitamin D in children.
A National consultative committee was formed that comprised of clinicians, epidemiologists, endocrinologists, and nutritionists. The Committee conducted deliberations on different aspects of vitamin D deficiency and rickets through ten online meetings between March and September, 2021. A draft guideline was formulated, which was reviewed and approved by all Committee members.
The group reiterates the serum 25-hydroxy vitamin D cutoffs proposed for vitamin D deficiency, insufficiency, and sufficiency as <12 ng/mL, 12-20 ng/mL and >20 ng/mL, respectively. Vitamin D toxicity is defined as serum 25OHD >100 ng/mL with hypercalcemia and/or hypercalciuria. Vitamin D supplementation in doses of 400 IU/day is recommended during infancy; however, the estimated average requirement in older children and adolescents (400-600 IU/day, respectively) should be met from diet and natural sources like sunlight. Rickets and vitamin D deficiency should be treated with oral cholecalciferol, preferably in a daily dosing schedule (2000 IU below 1 year of age and 3000 IU in older children) for 12 weeks. If compliance to daily dosing cannot be ensured, intermittent regimens may be prescribed for children above 6 months of age. Universal vitamin D supplementation is not recommended in childhood pneumonia, diarrhea, tuberculosis, HIV and non-infectious conditions like asthma, atopic dermatitis, and developmental disorders. Serum 25-hydroxy vitamin D level of >20 ng/mL should be maintained in children with conditions at high-risk for vitamin deficiency, like nephrotic syndrome, chronic liver disease, chronic renal failure, and intake of anticonvulsants or glucocorticoids.
关于印度维生素D缺乏症的患病率、佝偻病的预防和治疗策略以及维生素D的骨骼外益处的新文献表明,有必要修订印度现有的维生素D缺乏症预防和治疗指南。
回顾关于维生素D患病率和普遍补充维生素D必要性的新文献。提出针对无症状和有症状维生素D缺乏症以及佝偻病的最佳维生素D治疗方案。评估维生素D对儿童骨骼外健康的益处。
成立了一个国家咨询委员会,成员包括临床医生、流行病学家、内分泌学家和营养学家。该委员会在2021年3月至9月期间通过十次在线会议,就维生素D缺乏症和佝偻病各方面进行了讨论。制定了一份指南草案,并经所有委员会成员审核批准。
该小组重申,维生素D缺乏、不足和充足的血清25-羟基维生素D临界值分别提议为<12 ng/mL、12 - 20 ng/mL和>20 ng/mL;维生素D毒性定义为血清25OHD>100 ng/mL且伴有高钙血症和/或高钙尿症。婴儿期建议每日补充400 IU维生素D;然而,大龄儿童和青少年的估计平均需求量(分别为400 - 600 IU/天)应从饮食和阳光等天然来源获取。佝偻病和维生素D缺乏症应采用口服胆钙化醇治疗,最好采用每日给药方案(1岁以下儿童2000 IU,大龄儿童3000 IU),持续12周。如果无法确保每日按时服药,6个月以上儿童可采用间歇给药方案。儿童患肺炎、腹泻、结核病、艾滋病毒以及哮喘、特应性皮炎和发育障碍等非传染性疾病时,不建议普遍补充维生素D。维生素D缺乏高危疾病(如肾病综合征、慢性肝病、慢性肾衰竭以及服用抗惊厥药或糖皮质激素)患儿的血清25-羟基维生素D水平应维持在 >20 ng/mL。